LifeHealthcare Group Limited (ASX:LHC) announces its results for the full year ending 30 June 2017.
LifeHealthcare delivered strong above market revenue growth and modest underlying earnings growth albeit EPS on an NPATA basis is only marginally up year on year. Revenue growth of 10.4% (9.1% organic growth) on the prior comparable period to $126.7 million was achieved with underlying EBITDA growth of 4.6% on the prior comparable period to $20.4 million.
For further information please download PDF attached:
Download this document